Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2020-09-28 to 2023-09-29
Current total value of award: $1158642
Description: FDABAA -20-00123 ROBUST IN VITRO/IN SILICO MODEL TO ACCELERATE GENERIC DRUG PRODUCT DEVELOPMENT FOR THE ORAL CAVITY ROUTE OF ADMINISTRATION